Filing Flows

Filing Flows › Innoviva (INVA) › Next earnings date

Innoviva (INVA) earnings: missed the estimate

Innoviva (INVA) reported on Nov 4, 2026 and missed the EPS estimate: −$1.03 against $0.34 (-402.9%). Revenue was $106M for Q3 2026, -2% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result−402.9% vs estimate
Beat rate60%

The last report

Innoviva reported revenue of $106M for the third quarter 2026 (-2% Y/Y), net loss $73.9M: Royalty $54.7M, Product $49.4M, License and Other Revenue $2.0M. How it makes money → · Every quarter →

Innoviva: EPS against the estimate, last 5 reportsInnoviva: EPS against the estimate, last 5 reportsEstimateReported$0.39$0.38Nov 25$0.42$0.47Feb 26$0.43$0.47May 26$0.50$0.56Aug 26$0.34−$1.03Nov 26
Latest (Nov 26): Estimate $0.34, Reported −$1.03.

Innoviva's latest quarter

Innoviva, Q3 2026: revenue $106M (-2% year over year), operating margin 39.7%, net loss $73.9M, operating cash flow $41.7M. The chart follows the revenue to costs, profit and cash.

Questions

Did Innoviva beat earnings?

Innoviva (INVA) reported on Nov 4, 2026 and missed the EPS estimate: −$1.03 against $0.34 (-402.9%).

When does INVA report earnings?

The next date is not set yet.

Does Innoviva usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.